Vivos Therapeutics
VVOS
VVOS
30 hedge funds and large institutions have $1.71M invested in Vivos Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
30
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$2.82M | |
| 2 | +$81.4K | |
| 3 | +$79.6K | |
| 4 |
Renaissance Technologies
New York
|
+$63.8K |
| 5 |
VF
Virtu Financial
New York
|
+$40.3K |
Top Sellers
| 1 | -$30.8K | |
| 2 | -$25.8K | |
| 3 | -$11.1K | |
| 4 |
WAAG
Wealth Alliance Advisory Group
Wichita,
Kansas
|
-$7.66K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.53K |